Skip to main content
Journal cover image

Characterizing sources of variability in zebrafish embryo screening protocols.

Publication ,  Journal Article
Hamm, JT; Ceger, P; Allen, D; Stout, M; Maull, EA; Baker, G; Zmarowski, A; Padilla, S; Perkins, E; Planchart, A; Stedman, D; Tal, T; Volz, DC ...
Published in: ALTEX
January 2019

There is a need for fast, efficient, and cost-effective hazard identification and characterization of chemical hazards. This need is generating increased interest in the use of zebrafish embryos as both a screening tool and an alternative to mammalian test methods. A Collaborative Workshop on Aquatic Models and 21st Century Toxicology identified the lack of appropriate and consistent testing protocols as a challenge to the broader application of the zebrafish embryo model. The National Toxicology Program established the Systematic Evaluation of the Application of Zebrafish in Toxicology (SEAZIT) initiative to address the lack of consistent testing guidelines and identify sources of variability for zebrafish-based assays. This report summarizes initial SEAZIT information-gathering efforts. Investigators in academic, government, and industry laboratories that routinely use zebrafish embryos for chemical toxicity testing were asked about their husbandry practices and standard protocols. Information was collected about protocol components including zebrafish strains, feed, system water, disease surveillance, embryo exposure conditions, and endpoints. Literature was reviewed to assess issues raised by the investigators. Interviews revealed substantial variability across design parameters, data collected, and analysis procedures. The presence of the chorion and renewal of exposure media (static versus static-renewal) were identified as design parameters that could potentially influence study outcomes and should be investigated further with studies to determine chemical uptake from treatment solution into embryos. The information gathered in this effort provides a basis for future SEAZIT activities to promote more consistent practices among researchers using zebrafish embryos for toxicity evaluation.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

ALTEX

DOI

EISSN

1868-8551

ISSN

1868-596X

Publication Date

January 2019

Volume

36

Issue

1

Start / End Page

103 / 120

Related Subject Headings

  • Zebrafish
  • Toxicology
  • Toxicity Tests
  • High-Throughput Screening Assays
  • Embryonic Development
  • Embryo, Nonmammalian
  • Drug Evaluation, Preclinical
  • Chorion
  • Animals
  • 42 Health sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hamm, J. T., Ceger, P., Allen, D., Stout, M., Maull, E. A., Baker, G., … Walker, N. J. (2019). Characterizing sources of variability in zebrafish embryo screening protocols. ALTEX, 36(1), 103–120. https://doi.org/10.14573/altex.1804162
Hamm, Jon T., Patricia Ceger, David Allen, Matt Stout, Elizabeth A. Maull, Greg Baker, Amy Zmarowski, et al. “Characterizing sources of variability in zebrafish embryo screening protocols.ALTEX 36, no. 1 (January 2019): 103–20. https://doi.org/10.14573/altex.1804162.
Hamm JT, Ceger P, Allen D, Stout M, Maull EA, Baker G, et al. Characterizing sources of variability in zebrafish embryo screening protocols. ALTEX. 2019 Jan;36(1):103–20.
Hamm, Jon T., et al. “Characterizing sources of variability in zebrafish embryo screening protocols.ALTEX, vol. 36, no. 1, Jan. 2019, pp. 103–20. Epmc, doi:10.14573/altex.1804162.
Hamm JT, Ceger P, Allen D, Stout M, Maull EA, Baker G, Zmarowski A, Padilla S, Perkins E, Planchart A, Stedman D, Tal T, Tanguay RL, Volz DC, Wilbanks MS, Walker NJ. Characterizing sources of variability in zebrafish embryo screening protocols. ALTEX. 2019 Jan;36(1):103–120.
Journal cover image

Published In

ALTEX

DOI

EISSN

1868-8551

ISSN

1868-596X

Publication Date

January 2019

Volume

36

Issue

1

Start / End Page

103 / 120

Related Subject Headings

  • Zebrafish
  • Toxicology
  • Toxicity Tests
  • High-Throughput Screening Assays
  • Embryonic Development
  • Embryo, Nonmammalian
  • Drug Evaluation, Preclinical
  • Chorion
  • Animals
  • 42 Health sciences